Researchers
Bila, Jelena
Type
- 104 Conference Paper
- 69 Article
- 3 Monograph
- 1 Doctoral theses
- 1 Other
- 1 Reviews
Date issued
- 38 2020 - 2027
- 113 2010 - 2019
- 28 2000 - 2009
Results 21-40 of 179
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2022 | Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial | Terpos, Evangelos; ...; Bila, Jelena S.   ; ...; (broj koautora 23) | Article | 21aM21a |
| 2022 | Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis - case report and literature review | Jovićević, Vanja; Bila, Jelena S. ; Mesaroš, Šarlota T. ; Pekmezović, Tatjana D ; Drulović, Jelena S. | Article | 23M23 |
| 2022 | Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Overall Survival Results from the Phase 3 Apollo Study | Dimopoulos, Meletios A.; Terpos, Evangelos; Boccadoro, Mario; Delimpasi, Sosana; Beksac, Meral; Katodritou, Eirini; Moreau, Philippe; Baldini, Luca; Symeonidis, Argiris; Bila, Jelena S. ;
Oriol, Albert; Mateos, Maria-Victoria; Einsele, Hermann; Orfanidis, Ioannis; Kampfenkel, Tobias; Liu, Weiping; Kosh, Michele; NamPhuong, Tran; Carson, Robin; Sonneveld, Pieter;
| Conference Paper | Mp. category will be shown later |
| 2021 | Ultra-high-risk prognostic significance of double and triple hit myeloma | Bila, Jelena S. ; Mitrović, Marko; Bukumirić, Zoran M. ; Jovanović, Jelica V.; Denčić-Fekete, Marija ; Sretenović, Aleksandra M.; Jeličić, Jelena J. ; Perić, Teodora; Mihaljević, Biljana S. ; Antić, Darko A. | Conference Paper | Mp. category will be shown later |
| 2021 | A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome | Beksac, Meral; Seval, Guldane Cengiz; Kanellias, Nicholas; Coriu, Daniel; Rosinol, Laura; Ozet, Gulsum; Goranova-Marinova, Vesselina; Unal, Ali; Bila, Jelena S. ; Ozsan, Hayri;
Ivanaj, Arben; Ibricevic-Balic, Lejla; Kastritis, Efstathios; Blade, Joan; Dimopoulos, Meletios Athanasios;
| Other | Mp. category will be shown later |
| 2021 | Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial | Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S. ; ...; (broj koautora 23) | Article | 21a+M21a+ |
| 2021 | The implication and consequence of CD34+cell/subset quantity/ratio on the clinical outcome of hematologic malignancies treated by autologous stem cell transplants | Todorović, Milena R. ; Pavlović, Mirjana A.; Bila, Jelena S. ; Balint, Bela J. | Conference Paper | Mp. category will be shown later |
| 2021 | Prognostic impact of response-adjusted ISS score in Multiple Myeloma | Mitrović, Marko; Bukumirić, Zoran M. ; Sretenović, Aleksandra M.; Miketić, Ivana; Bila, Jelena S. | Conference Paper | Mp. category will be shown later |
| 2021 | Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO | Terpos, Evangelos; ...; Bila, Jelena S. ; ...; (broj koautora 20) | Conference Paper | Mp. category will be shown later |
| 2021 | Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study | Jagannath, Sundar; ...; Bila, Jelena S. ; ...; (broj koautora 45) | Conference Paper | Mp. category will be shown later |
| 2021 | Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group | Bila, Jelena S. ; Katodritou, Eirini; Guenova, Margarita; Basic-Kinda, Sandra; Coriu, Daniel; Dapcevic, Milena; Ibricevic-Balic, Lejla; Ivanaj, Arben; Karanfilski, Oliver; Zver, Samo;
Beksac, Meral; Terpos, Evangelos; Dimopoulos, Meletios Athanassios;
| Article | 21aM21a |
| 2021 | Pomalidomide and Dexamethasone with or without Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Updated Analysis of the Phase 3 Apollo Study | Sonneveld, Pieter; ...; Bila, Jelena S. ; ...; (broj koautora 21) | Conference Paper | Mp. category will be shown later |
| 2021 | APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM) | Einsele, Hermann; ...; Bila, Jelena S. ; ...; (broj koautora 23) | Conference Paper | Mp. category will be shown later |
| 2021 | Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases | Gerhardt, Kristin; ...; Sretenović, Aleksandra M.; ...; Todorović, Milena R. ; Bila, Jelena S. ; ...; Vučinić, Vladan | Article | 21M21 |
| 2020 | Induction of remission in a heavily pretreated patient with diffuse large B-cell lymphoma (DLBCL) who relapsed after the therapy with CAR-T-cells - case report | Küpper K.; Georgi, Thomas; Bach, Enrica; Leiblein, Sabine; Sretenović, Aleksandra M.; Hoffmann, S.; Tumewu, Theresa; Bila, Jelena S. ; Franke, Georg-Nikolaus; Platzbecker, Uwe;
Vučinić, Vladan
; | Conference Paper | Mp. category will be shown later |
| 2020 | Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial | Grosicki, Sebastian; ...; Bila, Jelena S. ; ...; (broj koautora 58) | Article | 21a+M21a+ |
| 2020 | Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants | Todorović-Balint, Milena ; Bila, Jelena ; Balint, Bela ; Jeličić, Jelena ; Đunić, Irena ; Antić, Darko ; Kraguljac-Kurtović, Nada ; Vujić, Dragana ; Mihaljević, Biljana | Article | 23M23 |
| 2020 | A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome | Beksac, Meral; Seval, Guldane Cengiz; Kanellias, Nicholas; Coriu, Daniel; Rosinol, Laura; Ozet, Gulsum; Goranova-Marinova, Vesselina; Unal, Ali; Bila, Jelena S. ; Ozsan, Hayri;
Ivanaj, Arben; Ibričević-Balić, Lejla; Kastritis, Efstathios; Blade, Joan; Dimopoulos, Meletios Athanasios;
| Article | 21aM21a |
| 2019 | Ultrastructural and morphometric analysis of enlarged platelets in congenital isolated asplenia | Marković, Olivera ; Martinović, Tamara ; Ćirić, Darko ; Trpinac, Dušan ; Čemerikić-Martinović, Vesna; Bumbaširević, Vladimir ; Bila, Jelena ; Marisavljević, Dragomir ; Kravić-Stevović, Tamara | Article | 23M23 |
| 2018 | 25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it? | Đurašinović, Vladislava T.; Mihaljević, Biljana ; Šipetić-Grujičić, Sandra B. ; Ignjatović, Svetlana ; Trajković, Goran ; Todorović-Balint, Milena R. ; Antić, Darko ; Bila, Jelena S. ; Anđelić, Boško M.; Jeličić, Jelena J. ;
Vuković, Vojin M.
; Nikolić, Aleksandra M. ; Klek, Stanislaw; | Article | 21aM21a |